Calmodulin-dependent activation of p38 and p42/44 mitogen-activated protein kinases contributes to c-fos expression by calcium in PC12 cells: modulation by nitric oxide

Brain Res Mol Brain Res. 2000 Jan 10;75(1):16-24. doi: 10.1016/s0169-328x(99)00280-6.

Abstract

Calcium and nitric oxide (NO) are important messengers for the activity-dependent immediate-early gene (IEG) expressions in neuronal cells. In the present study, we have investigated the roles of two mitogen-activated protein (MAP) kinases, extracellular signal-regulated protein kinase (ERK) and p38 MAP kinase (p38 kinase) in calcium- and NO-induced c-fos expression in PC12 cells. Membrane depolarization-induced calcium increases activated both ERK and p38 kinase within 5 min. The activation of both ERK and p38 kinase by calcium was a calmodulin-dependent process since the pretreatment of W13 or calmidazolium, specific calmodulin antagonists, blocked calcium-induced activation of both MAP kinases. Calcium-induced c-fos expression was significantly reduced by the pretreatment of either MEK inhibitor (PD98059) or p38 kinase inhibitor (SB203580). This finding indicates that the calmodulin-dependent activation of ERK and p38 kinase is involved in calcium-induced c-fos expression. However, sodium nitroprusside and SIN-1, known to release NO, dose-dependently activated only ERK. NO-induced c-fos expression was partially inhibited by the PD98059. We also observed that NO dose-dependently potentiates not only calcium-induced c-fos expression but also calcium-induced ERK activation. In the presence of PD98059, the amplification of calcium-induced c-fos expression by NO was not observed. This result suggests that calcium- and NO-signals converge into the MEK/ERK pathway, thereby enhance IEG expressions in neuronal cells.

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Calmodulin / antagonists & inhibitors
  • Calmodulin / metabolism*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Gene Expression Regulation, Neoplastic / drug effects
  • Genes, fos* / drug effects
  • Imidazoles / pharmacology
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / metabolism*
  • Molsidomine / analogs & derivatives
  • Molsidomine / pharmacology
  • Nitric Oxide / physiology*
  • Nitric Oxide Donors / pharmacology*
  • Nitroprusside / pharmacology
  • Oxadiazoles / pharmacology
  • PC12 Cells
  • Potassium Chloride / pharmacology
  • Proto-Oncogene Proteins c-fos / biosynthesis
  • Proto-Oncogene Proteins c-fos / genetics
  • Pyridines / pharmacology
  • Quinoxalines / pharmacology
  • Rats
  • Sulfonamides / pharmacology
  • p38 Mitogen-Activated Protein Kinases

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Calmodulin
  • Enzyme Inhibitors
  • Flavonoids
  • Imidazoles
  • Nitric Oxide Donors
  • Oxadiazoles
  • Proto-Oncogene Proteins c-fos
  • Pyridines
  • Quinoxalines
  • Sulfonamides
  • Nitroprusside
  • Nitric Oxide
  • calmidazolium
  • linsidomine
  • Potassium Chloride
  • N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide
  • Molsidomine
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Calcium